We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$294M
AUM Growth
+$20.7M
Cap. Flow
+$5.39M
Cap. Flow %
1.83%
Top 10 Hldgs %
28.09%
Holding
92
New
25
Increased
25
Reduced
19
Closed
18

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$4.59M
2
ZTS icon
Zoetis
ZTS
+$4.07M
3
TMO icon
Thermo Fisher Scientific
TMO
+$3.62M
4
ZBH icon
Zimmer Biomet
ZBH
+$2.97M
5
SYK icon
Stryker
SYK
+$2.87M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$9.28M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$6.79M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.91M
4
MRK icon
Merck
MRK
+$4.77M
5
CAH icon
Cardinal Health
CAH
+$3.9M

Sector Composition

Rank Sector Weight
1 Healthcare 86.68%
2 Financials 2.98%
3 Energy 1.23%
4 Industrials 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNH icon
1
UnitedHealth
UNH
$382B
$8.81M 3%
45,000
-7,500
-14% -$1.45M
AET
2
DELISTED
Aetna Inc
AET
$8.75M 2.98%
55,000
+10,000
+22% +$1.56M
HUM icon
3
Humana
HUM
$43.9B
$8.53M 2.9%
35,000
– –
TMO icon
4
Thermo Fisher Scientific
TMO
$214B
$8.51M 2.9%
45,000
+20,000
+80% +$3.62M
ABBV icon
5
AbbVie
ABBV
$465B
$8.44M 2.87%
95,000
+35,000
+58% +$2.66M
ALXN
6
DELISTED
Alexion Pharmaceuticals
ALXN
$8.42M 2.86%
60,000
-50,000
-45% -$6.79M
CELG
7
DELISTED
Celgene Corp
CELG
$8.02M 2.73%
55,000
-5,000
-8% -$681K
CNC icon
8
Centene
CNC
$30.5B
$7.74M 2.63%
160,000
– –
WCG
9
DELISTED
Wellcare Health Plans, Inc.
WCG
$7.73M 2.63%
45,000
+10,000
+29% +$1.75M
VRTX icon
10
Vertex Pharmaceuticals
VRTX
$123B
$7.6M 2.59%
50,000
-5,000
-9% -$753K
BSX icon
11
Boston Scientific
BSX
$68.4B
$7.58M 2.58%
260,000
+20,000
+8% +$552K
BAX icon
12
Baxter International
BAX
$12.8B
$7.53M 2.56%
120,000
+20,000
+20% +$1.24M
ABT icon
13
Abbott
ABT
$187B
$7.47M 2.54%
140,000
+40,000
+40% +$2.01M
ELV icon
14
Elevance Health
ELV
$81.5B
$7.12M 2.42%
37,500
-2,500
-6% -$476K
SYK icon
15
Stryker
SYK
$135B
$7.1M 2.42%
50,000
+20,000
+67% +$2.87M
BIIB icon
16
Biogen
BIIB
$30.9B
$7.04M 2.4%
22,500
+2,500
+13% +$740K
BMRN icon
17
BioMarin Pharmaceuticals
BMRN
$11.9B
$6.98M 2.37%
75,000
-10,000
-12% -$884K
A icon
18
Agilent Technologies
A
$39.6B
$6.74M 2.29%
105,000
+25,000
+31% +$1.56M
CI icon
19
Cigna
CI
$78.4B
$6.54M 2.23%
35,000
-5,000
-13% -$890K
MOH icon
20
Molina Healthcare
MOH
$10.4B
$6.53M 2.22%
95,000
+12,500
+15% +$814K
GILD icon
21
Gilead Sciences
GILD
$165B
$6.48M 2.21%
80,000
-10,000
-11% -$765K
BDX icon
22
Becton Dickinson
BDX
$46.4B
$6.37M 2.17%
33,313
+7,688
+30% +$1.49M
RVTY icon
23
Revvity
RVTY
$12.6B
$6.21M 2.11%
90,000
+10,000
+13% +$671K
INCY icon
24
Incyte
INCY
$25.8B
$5.25M 1.79%
45,000
-15,000
-25% -$1.9M
DHR icon
25
Danaher
DHR
$138B
$4.72M 1.61%
+62,040
New +$4.59M
1
2 3 4

Similar funds

RSF
Rik Saylor Financial Fairfield, Ohio $132M AUM 16.04% 1-Year Est. Return
VF
Visa Foundation San Francisco, California $132M AUM 14.62% 1-Year Est. Return
AFP
ATX Financial Planning Austin, Texas $132M AUM
GCM
Graver Capital Management Columbus, Ohio $132M AUM 16.79% 1-Year Est. Return
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
FF
Fairway Financial Casselberry, Florida $132M AUM 13.23% 1-Year Est. Return
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM

Sivik Global Healthcare's Q3 2017 Portfolio in Review

As of Q3 2017, Sivik Global Healthcare held 92 positions worth $294M, up 7.6% from $273M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Sivik Global Healthcare's Q3 2017 filing shows 25 new, 25 increased, 19 reduced and 18 closed positions. Its largest new stake was Danaher: 62,040 shares worth $4.72M. The largest sale was Johnson & Johnson, an estimated $9.28M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, down from 88% a quarter earlier, followed by Financials and Energy.

  • Sivik Global Healthcare's largest Q3 2017 buy was Danaher: 62,040 shares worth $4.72M.
  • Sivik Global Healthcare added most to Thermo Fisher Scientific in Q3 2017, an estimated $3.62M increase.
  • Sivik Global Healthcare's biggest Q3 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $6.79M.
  • Sivik Global Healthcare fully exited Johnson & Johnson in Q3 2017, selling an estimated $9.28M.
  • Sivik Global Healthcare's ten largest holdings make up 28% of its $294M portfolio in Q3 2017.
  • Sivik Global Healthcare opened 25 new positions and closed 18 in Q3 2017.
  • Sivik Global Healthcare's portfolio value rose 7.6% quarter-over-quarter to $294M.

Based on Sivik Global Healthcare's 13F filing for Q3 2017, filed 8 Nov 2017.